Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE

Driving Innovation in MedTech: An Interview with David Phasey

Driving Innovation in MedTech: An Interview with David Phasey

From home dialysis and hip replacements to rethinking one of medicine’s oldest devices, we’ve spent the last 20 years solving the engineering...

Read More
How do you keep your DPI filling process running reliably shift after shift?

How do you keep your DPI filling process running reliably shift after shift?

There are three main approaches to filling blisters with dry powder for inhalation: vacuum drum, membrane dosing and partial compaction and each has...

Read More
CAR-T cell therapy for cancer: The patient's in the process

CAR-T cell therapy for cancer: The patient's in the process

Around 1,000 people are diagnosed with cancer every day in the UK. Fortunately, outcomes continue to improve, with around half of those diagnosed...

Read More